H. Haapasalo et al., Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas, NEUROP AP N, 25(2), 1999, pp. 134-142
We have analysed 78 cerebellar pilocytic astrocytomas to assess whether his
topathology, cell proliferation, apoptosis rate, p53 immunoreactivity, or f
low cytometry could predict their long-term behaviour. Classic pilocytic/mi
crocystic pattern was seen in 62 patients and 16 patients had mixed pattern
with an additional non-pilocytic glial component. The overall 5-year survi
val was 93%, complete resection providing 100% survival. The four patients
who died during the follow-up were more than 14 years of age, their primary
operation had been incomplete and three of them were mixed variants. In 15
cases the tumour recurred giving a recurrence-free 5-year survival of 77%.
The proliferation indices were low: Ki-67(MIB-1) (median 2.0%), PCNA (1.2%
) and S-phase fraction (4.4%). The Ki-67(MIB-1)-labelling index was signifi
cantly higher in young patients, but did not differ between the classic, an
d mixed variants. Twenty-two per cent of the tumours were aneuploid with a
significantly higher S-phase fraction than in diploid tumours, p53 seems to
act as 'guardian of the genome' in pilocytic astrocytomas, because aberran
t/increased expression of p53 and aneuploidy associated with enhanced apopt
osis, Only patient age (P=0.01), radicality of the primary operation (P=0.0
001) and histology (classic vs mixed, P=0.008) significantly correlated wit
h survival. The poorer prognosis of the mixed variant suggests that this ma
y represent a distinct entity. Although none of the novel parameters signif
icantly predicted recurrence or survival, they indicate substantial biologi
cal variation among cerebellar pilocytic astrocytomas.